Refine by
Clinical Value Equipment Supplied In Germany
5 equipment items found
Manufactured by:CAmed Medical Systems GmbH based inLeverkusen, GERMANY
Its excellent image performance plays an important role in the prevention and early detection in primary medical care, enriching the diagnostic application and enhancing the clinical ...
Manufactured by:Sysmex Partec GmbH based inGoerlitz, GERMANY
The new UC-3500 is a fully automated urine chemistry analyser that offers particularly high clinical value. Urine sample material is dropped onto each pad of a dedicated test strip within the analyser. The entire sequence, starting from sample aspiration, to colour comparison and final output of the results is fully automatic. In addition to the five system ...
Manufactured by:Sysmex Partec GmbH based inGoerlitz, GERMANY
The new UC-1000 integrates within your urinalysis workflow in many ways. Whether you are looking for a backup for your UC-3500 fully automated system or require a smaller system for processing individual test strip order requests, UC-1000 is equally well suited. You can set it up stand-alone or integrated into your UN-Series solution. You can choose between different test strips for the UC-1000: ...
Manufactured by:Shimadzu Europa GmbH based inDuisburg, GERMANY
With over a century of manufacturing experience, Shimadzu has established itself as a leader in the medical industry by offering reliable, cost-effective, and high-quality X-ray systems. The RADspeed Pro EDGE is a state-of-the-art digital radiographic system that enhances productivity and user-operability while ensuring patient comfort and safety. It integrates innovative imaging techniques like ...
Manufactured by:Therawis based inMunich, GERMANY
The acute SARS-CoV-2 infection is diagnosed routinely through PCR-based detection of viral RNA from nasopharyngeal swabs. Additionally, direct antigen detection of viral proteins is now available. The specific detection by PCR has a high sensitivity and specificity but delivers a false-negative rate of up to 38 % at the time of symptoms (Kucirka et al. 2020). The sensitivity and specificity of ...